Nelissen I - Search Results

1

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9).

Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Van den Steen PE, et al. Among authors: nelissen i. Crit Rev Biochem Mol Biol. 2002 Dec;37(6):375-536. doi: 10.1080/10409230290771546. Crit Rev Biochem Mol Biol. 2002. PMID: 12540195 Review.

2

Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development.

Fiten P, Vandenbroeck K, Dubois B, Van Coillie E, Nelissen I, Van Damme J, Ligers A, Hillert J, Andersson M, Olsson T, Opdenakker G. Fiten P, et al. Among authors: nelissen i. J Neuroimmunol. 1999 Mar 1;95(1-2):195-201. doi: 10.1016/s0165-5728(99)00007-7. J Neuroimmunol. 1999. PMID: 10229131

3

Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis.

Nelissen I, Vandenbroeck K, Fiten P, Hillert J, Olsson T, Marrosu MG, Opdenakker G. Nelissen I, et al. J Neuroimmunol. 2000 Jun 1;105(1):58-63. doi: 10.1016/s0165-5728(00)00189-2. J Neuroimmunol. 2000. PMID: 10713364

4

PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia.

Nelissen I, Fiten P, Vandenbroeck K, Hillert J, Olsson T, Marrosu MG, Opdenakker G. Nelissen I, et al. J Neuroimmunol. 2000 Aug 1;108(1-2):153-9. doi: 10.1016/s0165-5728(00)00293-9. J Neuroimmunol. 2000. PMID: 10900349

5

Gelatinase B functions as regulator and effector in leukocyte biology.

Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J. Opdenakker G, et al. Among authors: nelissen i. J Leukoc Biol. 2001 Jun;69(6):851-9. J Leukoc Biol. 2001. PMID: 11404367 Review.

6

Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta.

Nelissen I, Ronsse I, Van Damme J, Opdenakker G. Nelissen I, et al. J Leukoc Biol. 2002 Jan;71(1):89-98. J Leukoc Biol. 2002. PMID: 11781384

7

Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis.

Nelissen I, Dubois B, Goris A, Ronsse I, Carton H, Opdenakker G. Nelissen I, et al. J Neurol Sci. 2002 Aug 15;200(1-2):43-8. doi: 10.1016/s0022-510x(02)00129-6. J Neurol Sci. 2002. PMID: 12127674

8

Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.

Nelissen I, Martens E, Van den Steen PE, Proost P, Ronsse I, Opdenakker G. Nelissen I, et al. Brain. 2003 Jun;126(Pt 6):1371-81. doi: 10.1093/brain/awg129. Brain. 2003. PMID: 12764058

9

Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.

Dubois B, Leary SM, Nelissen I, Opdenakker G, Giovannoni G, Thompson AJ. Dubois B, et al. Among authors: nelissen i. J Neurol. 2003 Sep;250(9):1037-43. doi: 10.1007/s00415-003-0110-8. J Neurol. 2003. PMID: 14504963 Clinical Trial.

10

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis.

Opdenakker G, Nelissen I, Van Damme J. Opdenakker G, et al. Among authors: nelissen i. Lancet Neurol. 2003 Dec;2(12):747-56. doi: 10.1016/s1474-4422(03)00587-8. Lancet Neurol. 2003. PMID: 14636780 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters